American Creek Litigation Update-Teuton Resources Corp. Denied Stay

equities Canada |

CARDSTON, ALBERTA--(Feb. 2, 2015) - American Creek Resources Ltd. ($AMK:CA) (the "Corporation") wishes to provide a further update in the litigation with Teuton Resources Corp. ("Teuton").

TEUTON'S STAY APPLICATION DENIED

The Corporation reports that on February 2, 2015 Teuton's application for a stay of the enforcement proceedings against Teuton by the Corporation (see the Corporation's press release dated January 26, 2015) was denied by the British Columbia Court of Appeal. The Corporation will proceed with enforcement of its judgment against Teuton.

APPEAL HEARING

As previously reported, the Corporation was successful at trial in the litigation with Teuton over ownership of the Treaty Creek property. Teuton has appealed the Court's decision. The British Columbia Court of Appeal will hear the appeal on March 9-11, 2015.

SPECIAL COSTS HEARING



The hearing to determine the amount of special costs owed by Teuton to the Corporation will be held March 31 and April 1, 2015.

CONSPIRACY / DEFAMATION LITIGATION

The litigation against Teuton, Teuton's president Dino Cremonese, and others for conspiracy and defamation will proceed.

The Corporation will continue to provide litigation updates as these matters progress.

American Creek Resources Ltd. is a Canadian junior mineral exploration company focused on the acquisition, exploration and development of mineral deposits within the Province of British Columbia, Canada.

Information relating to the Corporation is available on its website at www.americancreek.com.

Contact Information

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.